- $45.91m
- $46.67m
- $0.16m
Annual income statement for Daxor, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | N-CSR | N-CSR | N-CSR | N-CSR | N-CSR |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.38 | 0.264 | 0.278 | 0.232 | 0.163 |
| Cost of Revenue | |||||
| Gross Profit | -0.109 | -0.298 | -0.694 | -0.887 | -0.646 |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.524 | 0.743 | 1.09 | 1.2 | 1.05 |
| Operating Profit | -0.144 | -0.478 | -0.815 | -0.973 | -0.886 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.496 | -1.73 | 4.75 | 5.18 | 0.281 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.496 | -1.71 | 4.75 | 5.18 | 0.281 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.496 | -1.71 | 4.75 | 5.18 | 0.281 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.496 | -1.71 | 4.75 | 5.18 | 0.281 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.132 | -0.433 | 1.18 | 1.21 | 0.058 |